scholarly journals Nonmelanoma skin cancer in the population of the city of Belgrade in the period 1999-2011

2015 ◽  
Vol 143 (5-6) ◽  
pp. 290-295 ◽  
Author(s):  
Goran Videnovic ◽  
Dragan Miljus ◽  
Danijela Ilic ◽  
Dragan Krasic ◽  
Snezana Zivkovic
Keyword(s):  
Skin Cancer ◽  
Incidence Rate ◽  
Squamous Cell ◽  
Basal Cell ◽  
Nonmelanoma Skin Cancer ◽  
Skin Carcinoma ◽  
Skin Cancers ◽  
Nonmelanoma Skin Cancers ◽  
The City ◽  
Squamous Cell Skin Carcinoma

Introduction. Nonmelanoma skin cancers in the literature are mainly related to basal cell and squamous cell skin carcinoma. Objective. The aim of the study was to determine the trend in the incidence of histological types of nonmelanoma skin cancers in the population of the city of Belgrade from 1999 to 2011. Methods. From the Serbian National Cancer Registry we extracted all recorded cases of skin cancer in Belgrade from January 1st 1999 to December 31st 2011. Incidence rates were standardized by the method of direct standardization with the world population as the standard population. Trends and annual percentage change (APC) of incidence rate were calculated by performing joinpoint regression analyses. Results. Incidence rate of nonmelanoma skin cancer showed significantly increasing trend between 1999 and 2006 with APC of 8.6% (95% CI: 5.6-11.7), basal cell carcinoma increased with APC of 8.4% (95% CI: 5.2-11.6) and squamous cell skin carcinoma with APC of 9.33% (95% CI: 5.7-13.1). The incidence increased with age for both men and women, especially after the age of 60. Conclusion. Our results showed a continuously increasing incidence trend of both basal cell and squamous cell skin carcinomas in the population of the city of Belgrade between 1999 and 2011. Adequate primary and secondary prevention would certainly be successful in reducing this type of cancer in the future.

scholarly journals Margin Status in Shave Biopsies of Nonmelanoma Skin Cancers: Is It Worth Reporting?

2016 ◽  
Vol 140 (7) ◽  
pp. 678-681 ◽  
Author(s):  
Alicia M. Schnebelen ◽  
Jerad M. Gardner ◽  
Sara C. Shalin
Keyword(s):  
Skin Cancer ◽  
Squamous Cell ◽  
Basal Cell ◽  
Positive Margin ◽  
Margin Status ◽  
Positive Margins ◽  
Reporting Practices ◽  
Skin Cancers ◽  
Basal Cell Carcinomas ◽  
Nonmelanoma Skin Cancers

Context.—The practice of reporting margin status in biopsies is relatively unique to biopsies of the skin and highly variable among pathologists. Objective.—To address the accuracy of margin evaluation in shave biopsies of nonmelanoma skin cancers. Design.—We collected shave biopsies of squamous and basal cell carcinomas that appeared to have uninvolved margins on routine sign out. We obtained deeper levels on corresponding tissue blocks until blocks were exhausted and examined them for tumor at biopsy margins. Results.—Forty-seven consecutive cases were collected, including 20 squamous cell (43%) and 27 basal cell (57%) carcinomas. Eleven of 47 cases (23%) with negative margins at initial diagnosis demonstrated positive margins upon deeper-level examination. Margins of 8 of 27 basal cell carcinomas (30%) and 3 of 20 squamous cell carcinomas (15%) were erroneously classified as “negative” on routine examination. Conclusions.—No guidelines exist regarding the reporting of margins in nonmelanoma skin cancer biopsies, and reporting practices vary extensively among pathologists. We found that nearly one-quarter of positive margins in shave biopsies for cutaneous carcinomas are missed on standard histologic examination. Moreover, reporting of a positive margin may also be misleading if the clinician has definitively treated the skin cancer at the time of biopsy. For these reasons, and as routine exhaustion of all tissue blocks is impractical, the decision to include or exclude a comment regarding the margin status should be given conscious consideration, accounting for the clinical intent of the biopsy and any known information regarding postbiopsy treatment.

Dermatology

2016 ◽  
pp. 297-314
Author(s):  
Carilyn N. Wieland
Keyword(s):  
Cell Carcinoma ◽  
Squamous Cell ◽  
Basal Cell ◽  
The United States ◽  
Non Hodgkin Lymphoma ◽  
Exposed Skin ◽  
Skin Cancers ◽  
Clinical Presentations ◽  
History Of ◽  
Nonmelanoma Skin Cancers

Nonmelanoma skin cancers (basal cell carcinoma, squamous cell carcinoma) are the most common malignancies in the United States. Both basal cell and squamous cell carcinomas commonly occur on sun-exposed skin areas. The strongest risk factors for melanoma are a family history of melanoma, multiple benign or atypical nevi, and a previous melanoma. Cutaneous T-cell lymphoma is a non-Hodgkin lymphoma characterized by expansion of malignant T cells within the skin. The most common clinical presentations are mycosis fungoides and Sézary syndrome.

Multifokale Neoplasien der Haut: Biologie, Ätiologie und zielgerichtete Therapien von nicht-melanozytärem Hautkrebs

2018 ◽  
Vol 6 (3) ◽  
pp. 135-146
Author(s):  
Ana R. Fernandes ◽  
Ana C. Santos ◽  
Elena Sanchez-Lopez ◽  
Andjekla B. Kovačević ◽  
Marta Espina ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Basal Cell ◽  
Photodynamische Therapie ◽  
Zielgerichtete Therapien ◽  
Aktinische Keratose ◽  
Skin Cancers ◽  
Nonmelanoma Skin Cancers

Neoplastische Hautläsionen sind multifokal auftretende, diffuse Hautinfiltrationen, die besonders in der Differentialdiagnose ulzerativer, nodulärer oder verkrustender Hautläsionen von Bedeutung sind. Nicht-melanozytäre Hautkrebsformen (nonmelanoma skin cancers, NMSC) wie das Basalzellkarzinom (basal cell carcinoma, BCC), das Plattenepithelkarzinom (squamous cell carcinoma, SCC) und die aktinische Keratose (AK) sind die häufigsten malignen Tumoren beim Menschen. BCC wachsen langsam und bilden meist keine Metastasen, wohingegen SCC ein stärker infiltrierendes, destruierendes Wachstum zeigen und Metastasen bilden. AK sind Vorstufen des kutanen SCC. Bei der klassischen NMSC-Therapie kommt die photodynamische Therapie in Verbindung mit Chemotherapeutika zur Anwendung. Das zunehmende Verständnis der Pathomechanismen, die bei der Tumorentstehung, -progression und -differenzierung eine Rolle spielen, stützt die Anwendung zielgerichteter Chemotherapien zur Verringerung der Zytotoxizität klassischer Therapien. Die vorliegende Übersichtsarbeit beschreibt den aktuellen Wissensstand über NMSC, einschließlich der Risikofaktoren, Onkogene und Karzinogenese von Hautkrebs und erörtert die herkömmliche Behandlung im Vergleich zu neuartigen therapeutischen Optionen. Übersetzung aus Skin Pharmacol Physiol 2018;31:59-73 (DOI: 10.1159/000479529)

scholarly journals Histopathological pattern of skin cancer at tertiary referral skin health centre

2019 ◽  
Vol 9 (2) ◽  
pp. 1555-1559
Author(s):  
Ram Chandra Adhikari ◽  
Mahesh Shah ◽  
Anil Kumar Jha
Keyword(s):  
Squamous Cell Carcinoma ◽  
Skin Cancer ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Basal Cell ◽  
Verrucous Carcinoma ◽  
Health Centre ◽  
Female Ratio ◽  
Skin Cancers

Background: The skin is a heterogeneous organ, capable of producing various types of skin tumors. The incidence of skin cancers, including melanoma and non-melanoma has been reported to have risen in many parts of the world. In Asian and African countries, individuals with pigmented races have a much lower incidence of skin cancers despite sunny hot weather. This study is aimed to analyze age, sex and site wise of distribution of skin cancers. Materials and Methods: The study included a total of 60 patients with histopathologically proven skin cancers from January 2015 to December 2018 in the department of pathology, DI skin health and referral centre, Kathmandu, Nepal. Results: A total of 60 cases of histopathologically proven skin cancer constituted 3.69% of total skin biopsies. Patient age ranged from 15 to 88 years with mean age being 61 years. The majority of the patients were in the age group of 61-70 yrs. The male to female ratio is 1:1.3. Basal cell carcinoma was the most common skin cancer constituting 43.4%, followed by squamous cell carcinoma (28.3%). The most common site of skin cancer is head & neck (73.3%), followed by lower extremities (8.3%). Other skin cancers were Bowen’s disease, melanoma, verrucous carcinoma, keratoacanthoma, trichilemmal carcinoma, extramammary Paget’s disease, Non-Hodgkin lymphoma and metastatic tumor. Conclusions: The most common type of skin cancer is basal cell carcinoma, followed by squamous cell carcinoma and head & neck being the commonest site.

scholarly journals Squamous Cell Skin Carcinoma in Systemic Lupus Erythematosus: Case Report and Literature Review

2020 ◽  
Vol 10 (5) ◽  
pp. 390-397
Author(s):  
S. V. Topolyanskaya
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Case Report ◽  
Skin Cancer ◽  
Squamous Cell ◽  
Lupus Erythematosus ◽  
Skin Carcinoma ◽  
Cytokine Release ◽  
Cytokine Release Syndrome ◽  
Systemic Lupus ◽  
Squamous Cell Skin Carcinoma

The case report of squamous cell skin carcinoma diagnosed in a patient with systemic lupus erythematosus 26 years after the onset of rheumatic disease is presented. The features of this case included the absence of skin manifestations of systemic lupus erythematosus, the occurrence of a tumor at the site of ulcers and trophic disorders on the leg, a long period (6 years) from the onset of a ulcerative defect on the leg to the diagnosis of skin cancer (despite multiple biopsies and consultations of various specialists), as well as the occurrence of a cytokine release syndrome, which directly led to the death of the patient after the first use of the immune checkpoint inhibitors. Possible causes of skin cancer in patients with systemic lupus erythematosus, as well as the features of the cytokine release syndrome after immunotherapy for oncological diseases, are discussed.

Increased incidence of non-melanomatous skin cancer in patients with chronic lymphocytic leukemia, an 11-year case-control study

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 19554-19554
Author(s):  
M. W. Schoen ◽  
P. S. Gable ◽  
A. M. Reese
Keyword(s):  
Skin Cancer ◽  
Chronic Lymphocytic Leukemia ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Basal Cell ◽  
Squamous Cell Carcinomas ◽  
Lymphocytic Leukemia ◽  
Skin Cancers ◽  
Increased Risk ◽  
Malignant Lesions

19554 Background: Chronic Lymphocytic Leukemia (CLL) is a disease of B lymphocytes that affects immune tolerance and surveillance. Patients with CLL have an increased risk of basal and squamous cell skin carcinomas, which tend to be aggressive. We report the incidence of non-melanomatous (NM) in a >80% Caucasian cohort of patients with CLL and compared them to normal controls who reside in Southern California. Methods: A retrospective review was conducted of all patients in the Naval Medical Center San Diego tumor registry with CLL diagnosed between Jan 1, 1995 and Dec 31, 2005. The electronic records of 74 CLL patients and 100 control patients from the internal medicine clinic were assessed for skin biopsies performed at our institution revealing NM skin malignancies. Results: Within our CLL population, the average age at diagnosis was 72.2 years. 34% (25/74) had NM skin cancer with an incidence of 11,457 NM skin cancers per 100,000 person-years. The average number of malignant lesions was 3.7 per patient with one patient receiving 17 biopsies. 27% (7/25) of CLL patients with NM skin cancer had only squamous cell carcinoma and 23% (6/25) had only basal cell carcinoma. 42% (11/25) of patients had both squamous and basal cell cancers and one had a Merkel cell carcinoma. In the control population, the average age at diagnosis was 76.4 years. 16% (16/100) had NM skin malignancies with an incidence of 5,333 NM skin cancers per 100,000 person-years. The average number of malignant lesions was 3.7 per patient with one patient receiving 28 biopsies. 63% (10/16) had basal cell carcinomas, only 25% (4/16) had squamous cell carcinomas and 13% (2/16) had both types of cancer. Conclusions: Patients with CLL are at increased risk of developing NM skin cancers, especially squamous cell carcinomas. Patients with CLL have a 2.1 times higher risk of developing NM skin cancer than our control population, who had an incredibly high rate of skin cancer compared to prior publications. CLL patients should be closely screened for cutaneous malignancies in order to excise them before they cause further morbidity. Increased surveillance is especially prudent for elderly patients with fair skin types who have been exposed to a large amount of UV-light. No significant financial relationships to disclose.

Mutations of Fas (APO-1/CD95) and p53 Genes in Nonmelanoma Skin Cancer

2003 ◽  
Vol 7 (2) ◽  
pp. 112-118 ◽  
Author(s):  
Laura Boldrini ◽  
Barbara Loggini ◽  
Silvia Gisfredi ◽  
Ylenia Zucconi ◽  
Fulvia Baldinotti ◽  
...  
Keyword(s):  
Skin Cancer ◽  
Squamous Cell ◽  
Basal Cell ◽  
Fas Ligand ◽  
Skin Diseases ◽  
Genetic Alterations ◽  
Nonmelanoma Skin Cancer ◽  
Squamous Cell Carcinomas ◽  
Coding Region ◽  
Ligand Expression

Background: There is considerable evidence that apoptosis plays an important role in the pathogenesis of a wide variety of skin diseases. Apoptosis failure may ensure the survival of transformed cells prone to sustain further genetic damage and it plays an important part in the development of tumors. Genetic alterations of Fas and p53, with consequent inactivation of gene protein products, may be involved in transcriptional downregulation of Fas. Objective: We investigated Fas and its ligand expression in 30 cases of nonmelanoma skin cancer, 19 basal cell and 11 squamous cell carcinomas, and we also analyzed Fas and p53 status, in an attempt to detect putative alterations. Method: Fas and its ligand expression were evaluated by RT-PCR; the promoter and the entire coding region of Fas, and the coding exons 4–9 of p53 were investigated by polymerase chain reaction, single strand conformation polymorphism, and DNA sequencing. Results: Fas alterations were found in 3/19 (15.8%) basal cell and in 4/11 (36.4%) squamous cell carcinomas. Five out of 25 cases (3/19 basal cell and 2/11 squamous cell carcinomas) were p53-mutated, and in the majority of these cases there were concomitant mutations of the Fas gene (χ2 test; p = 0.035). Conclusion: Taken together, our findings highlight an involvement of the Fas/Fas-ligand system in the development of skin cancer, suggesting that the loss of its apoptotic function, in some cases linked to p53 alterations, may contribute to the self-maintenance of cancer cells.

Sign in / Sign up

Export Citation Format

Share Document